ScienceDex / Researcher record
Laura J Van't Veer
- University of California, San Francisco · Pathology (NIH department code)
- University of California, San Francisco (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- Program Leader
- R01 Holder
- Early Career
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,582,905 | 3 | #7,942 |
| 2025 | $1,661,118 | 3 | #8,770 |
| 2026 | $5,702,392 | 2 | #2,277 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected3 records
- FY20253 records
- FY20262 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10469779Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Pathology
FY2024 award records by amount
NIH award records listing Laura J Van't Veer as a PI. Multi-PI records show the full award amount for context.
- 1P01CA281826-01A1P01Co-investigatorWISDOM: A platform to optimize subtype-specific screening and prevention$706.3Kaward amount
- 5R01CA255442-04R01Contact PIStrategy for combining circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) measures of tumor burden for prediction of response and outcome in neoadjuvant-treated early breast cancerUniversity of California, San Francisco · Pathology (NIH department code)$636.7Kaward amount
- 5P01CA210961-07P01Contact PIThe I SPY 2.2 TRIAL: Evolving to Imaging and Molecular Biomarker Response Directed Adaptive Sequential Treatment to Optimize Breast Cancer Outcomes$239.8Kaward amount
Award organization
Organizations that administered FY2024 awards listing Laura J Van't Veer as a PI.
FY2024 award administered by University of California, San Francisco (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of California, San Francisco
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7942
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$5M Cumulative Funding
- 2026Entered Top 25% NationallyRanked #2277
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Laura J Van't Veer.